Your next fundraise.
Less busywork.FOR THE PERSON RUNNING THE RAISE
Alessia VC helps you build a clearer investment case, identify evidence gaps and key risks, find relevant investors, and prepare tailored outreach, with less repetitive work.
Bring your investor list or explore potential matches. Turn your company information into consistent materials and email drafts, ready for you to review, edit and send.
Planned launch price: $49/month. No payment today. Currently in development.
Already using AI?
Put your AI drafts to work across the raise.
Running a raise means connecting your company’s facts, investment case, risk mitigation plans and investor research; then putting that context to work across your outreach. Alessia VC is being built to bring those pieces together.
01 / INVESTOR READINESS
Build a clearer investment case. Spot evidence gaps, distinguish targets from achieved results and clarify how you plan to address key risks before investor conversations.
02 / PREPARE ONCE
Start with one confirmed company brief. Reuse your facts and messaging across materials and emails, with less repeated prompting and rewriting.
03 / PRIORITIZE WITH CONTEXT
Understand why each investor may fit. Review fit reasons, sources and missing information so you can decide whom to approach and what needs checking.
04 / REVIEW IN BATCHES
Prepare tailored outreach across multiple prospects while keeping your company’s claims consistent. Review, edit and send through your existing workflow.
A clearer investment case.
More focused investor outreach.
Illustrative concept · Fictionalized genomics venture and investors · Not live software
A genomics venture preparing to launch, Avenora Genomics.
The company plans to establish a local genomic-testing laboratory to help clinicians receive results sooner. Its longer-term ambition is to develop data-driven services alongside clinical testing.
How could Alessia VC help prepare its investor campaign?
01 / INVESTOR READINESS
Connect the launch plan to the investment case.
Which clinical service launches first? Who pays for it? What must be in place before operations begin and which milestones would the funding support?
Alessia VC helps organize these questions, the available evidence and the founder’s plans to address key risks.
02 / PREPARE ONCE
Keep the operating business and growth story consistent.
The team confirms one company brief covering its initial services, customers, business model, launch milestones and longer-term opportunity.
That context supports the investment overview and email drafts, reducing repeated briefing and conflicting descriptions across materials.
03 / PRIORITIZE WITH CONTEXT
Healthcare interest alone does not establish investor fit.
Investor A / Potential fit
Its stated interests include early-stage diagnostic services. Investment geography and check size still need checking.Investor B / Business-model question
It focuses on scalable software. The team needs to establish whether a laboratory-led business falls within its mandate.Investor C / Apparent stage mismatch
It requires established commercial revenue. A venture preparing to launch does not currently meet that stated requirement.04 / REVIEW IN BATCHES
Adapt the relevance. Keep the company facts consistent.
For each selected prospect, Alessia VC prepares an email draft using the same confirmed brief and supported investor context.
The team reviews the relevance, edits the wording and decides what to send through its existing workflow.
CLAIM CHECK / AMBITION OR DEMONSTRATED RESULT?
“Results when clinicians need them” describes the intended benefit. Alessia VC prompts the team for measured turnaround times before presenting faster delivery as demonstrated performance.
Planned testing volumes and projected margins remain forecasts. Expressions of interest remain distinct from documented customer commitments.
RISK MITIGATION / WHAT SUPPORTS THE NEXT STEP?
A future data-driven business depends on more than collecting genomic information.
Alessia VC helps the team organize questions about consent, permitted use, data quality and commercial demand, and record its proposed actions, supporting evidence and unresolved uncertainties.
A planned action stays a plan until the founder confirms what has been completed.
One confirmed company brief. A clearer case. Relevant prospects. Outreach you control.
You confirm the facts, review the reasoning and decide what to send. Alessia VC does not validate clinical claims, certify compliance or guarantee investor responses.
From investment case to investor outreach.
Illustrative email based on the fictionalized genomics example above. Company and recipient names are placeholders.
Subject: Avenora Genomics preparing to launch
Hi Miriam,
Your stated interest in early-stage diagnostic services prompted me to reach out.
We’re preparing to establish a local genomic-testing laboratory, aiming to give clinicians access to results sooner than overseas testing allows. Our longer-term ambition includes data-driven services alongside clinical testing.
We’re preparing our raise and would welcome a conversation about whether a laboratory-led business at our stage fits your mandate, including your investment geography.
Would you be open to a 20-minute introductory conversation?
Best,
MartaCEO of Avenora Genomics
You review, edit and send. Alessia VC uses confirmed company facts and supported investor context. No email is sent automatically.
You’re running a company.
Let Alessia VC help with the raise.
Your fundraising assistant for $49/month.
Planned launch price
Build your investment case, work through key risks, research investors and prepare tailored outreach, with Alessia VC helping you move the work forward.
Less time on repetitive preparation. More attention for investor conversations and the company you’re building.
- Investor-readiness workspace to organize your investment case, identify evidence gaps and track key risks with plans to address them
- Ongoing readiness updates, so you can add evidence, revisit risks and update mitigation plans as your company progresses
- 1 company · 1 active fundraising campaign
- Up to 1,000 investor prospects organized with fit context
- 200 email packs per month, each with an initial draft and two follow-ups
- 10 investment-overview generations per month
- Unlimited manual editing of your company brief, readiness information and drafts
Bring your investor list, explore available prospects or find potential matches. Coverage and discovery limits apply. AI-readiness reassessments are subject to fair use.
Join the early-access waitlist
In development. Final features, allowances and fair-use terms will be confirmed before purchase.
No payment or subscription today. Cancel anytime once subscriptions are available.
Join the early-access waitlist
Be among the first to try Alessia VC.
Planned launch price: $49/month. Currently in development. No payment today, and joining does not create a subscription.
What would make Alessia VC worth $49/month to you?
Tell us the result you’d want to see or the concern you’d need resolved before subscribing.
This is optional, your waitlist signup is complete either way. Please don’t include confidential information.
Alessia VC
In development
No payment or subscription today
Contact
info@
You review and send your outreach.